While terms often are used interchangeably, they are very different technologies with different challenges.
Technology and business issues mean it won’t replace EUV, but photonics, biotech and other markets provide plenty of room for growth.
Commercial chiplet marketplaces are still on the distant horizon, but companies are getting an early start with more limited partnerships.
Existing tools can be used for RISC-V, but they may not be the most effective or efficient. What else is needed?
Existing EDA companies say it’s unlikely there will be a major change in the industry, but that is because they are not looking at true disruptions.
How customization, complexity, and geopolitical tensions are upending the global status quo.
The industry is gaining ground in understanding how aging affects reliability, but more variables make it harder to fix.
Key pivot and innovation points in semiconductor manufacturing.
